PubRank
Search
About
A Mejean
Author PubWeight™ 8.66
‹?›
Top papers
Rank
Title
Journal
Year
PubWeight™
‹?›
1
The use of partial nephrectomy in European tertiary care centers.
Eur J Surg Oncol
2008
1.16
2
Efficiency of Ber-EP4 antibody for isolating circulating epithelial tumor cells before RT-PCR detection.
Am J Clin Pathol
1999
1.05
3
Outpatient treatment with subcutaneous interleukin-2 and interferon alfa administration in combination with fluorouracil in patients with metastatic renal cell carcinoma: results of a sequential nonrandomized phase II study. Subcutaneous Administration Propeukin Program Cooperative Group.
J Clin Oncol
1998
0.97
4
A mu-opioid receptor-filter assay. Rapid estimation of binding affinity of ligands and reversibility of long-lasting ligand-receptor complexes.
Biochem Pharmacol
1988
0.85
5
[Angiogenesis inhibition: review of the activity of sorafenib, sunitinib and bevacizumab].
Bull Cancer
2010
0.81
6
Renal and adrenal gland localization of chronic myelomonocytic leukemia presenting as a kidney tumor.
Leuk Lymphoma
1999
0.79
7
[Are therapeutics decisions homogeneous in multidisciplinary onco-urology staff meeting? Comparison of therapeutic options taken in four departments from Paris].
Prog Urol
2012
0.79
8
[Prevention of renal carcinoma: the nutri-genetic approach].
J Soc Biol
2000
0.78
9
Re: Use of methylene blue and selective embolization of the pudendal artery for high flow priapism refractory to medical and surgical treatments.
J Urol
1993
0.77
10
Photoactivatable opiate derivatives as irreversible probes of the mu-opioid receptor.
J Med Chem
1990
0.77
11
[What may be the waiting time between the diagnosis and surgical treatment of kidney cancer?].
Prog Urol
2008
0.75
12
Photoaffinity labelling of the mu-opioid receptor is dependent on the nature of the photosensitive group of carfentanil derivatives.
Eur J Pharmacol
1990
0.75
13
The accuracy of renal tumor biopsy: analysis from a national prospective study.
World J Urol
2014
0.75
14
[Treatment of von Hippel-Lindau disease with renal involvement].
Prog Urol
1997
0.75
15
[Atypical cysts and cystic tumours of the kidney: histological, radiological and surgical considerations. Conclusions of the AFU 2007 forum].
Prog Urol
2008
0.75
16
Is there a place for isolated renal transplantation in the treatment of primary hyperoxaluria type 1? Experience from Paris.
Nephrol Dial Transplant
1995
0.75
17
[The place of laparoscopic nephrectomy in the elderly subject].
Prog Urol
2009
0.75
18
[Do ablative treatments modify the management of kidney tumors in the elderly?].
Prog Urol
2009
0.75
19
[Case report of kidney cancer from JOUM 2010].
Prog Urol
2011
0.75
20
[Kidney transplantation in the rat: An institutional technique].
Prog Urol
2010
0.75
21
[Renal-pleural fistula after radiofrequency ablation of renal tumor in VHL patient].
Prog Urol
2010
0.75
22
[Papillary renal cell carcinoma: morphological subtypes, clinical and histopathological considerations].
Prog Urol
2010
0.75
23
Evaluation of cell proliferation through a polymerase chain reaction-based cyclin A test.
Anal Biochem
1997
0.75
24
[Infiltrating cancer of the bladder: can radiochemotherapy be an alternative to cystectomy?].
J Urol (Paris)
1996
0.75
25
Polyglactin tie added to nonabsorbable polymer locking clips to control artery in laparoscopic living donor nephrectomy: better safe than sorry.
Transplant Proc
2009
0.75
26
New photoaffinity labels for rat brain muscarinic acetylcholine receptors.
Biochem Pharmacol
1989
0.75
27
[Renal oncocytoma: CT diagnostic criteria revisited].
J Radiol
2005
0.75
28
[The impact of partial nephrectomy on morbidity and on long-term oncological outcomes].
Prog Urol
2009
0.75
29
[Treatment of metastatic kidney cancer in elderly subjects].
Prog Urol
2009
0.75